Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 38, Issue 2, 2012, Pages 134-141

  Brandl, E J ^a   Frydrychowicz, C ^b   Tiwari, A K ^a   Lett, T A P ^a   Kitzrow, W ^b   Buttner S ^b   Ehrlich, S ^c   Meltzer, H Y ^d   Lieberman, J A ^e   Kennedy, J L ^a   Muller D J ^a   Puls, I ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Antipsychotic; Gene; Leptin; Leptin receptor; Polymorphism; Weight gain

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LEPTIN; LEPTIN RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; LEPTIN GENE; LEPTIN RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADULT; ALLELES; ANTIPSYCHOTIC AGENTS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LEPTIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, LEPTIN; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 84862895753     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.03.001     Document Type: Article

References (55)

1. Albaugh V.L., Singareddy R., Mauger D., Lynch C.J. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. PLoS One 2011, 6:e22662.
2. Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999, 156:1686-1696.
3. Basile V.S., Masellis M., De Luca V., Meltzer H.Y., Kennedy J.L. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 2002, 360:1790-1791.
4. Calarge C.A., Ellingrod V.L., Zimmerman B., Acion L., Sivitz W.I., Schlechte J.A. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatr Genet 2009, 19:320-327.
5. Calle M.L., Urrea V., Malats N., Van Steen K. mbmdr: an R package for exploring gene-gene interactions associated with binary or quantitative traits. Bioinformatics 2010, 26:2198-2199.
6. Comings D.E., MacMurray J.P. Molecular heterosis: a review. Mol Genet Metab 2000, 71:19-31.
7. De Luca V., Mueller D.J., de Bartolomeis A., Kennedy J.L. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol 2007, 10:697-704.
8. De Luca V., Muller D.J., Hwang R., Lieberman J.A., Volavka J., Meltzer H.Y., et al. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis. Hum Psychopharmacol 2007, 22:463-467.
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25:115-121.
10. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008, 66:87-98.
11. Ehrlich S., Burghardt R., Schneider N., Broecker-Preuss M., Weiss D., Merle J.V., et al. The role of leptin and cortisol in hyperactivity in patients with acute and weight-recovered anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:658-662.
12. Ellingrod V.L., Bishop J.R., Moline J., Lin Y.C., Miller D.D. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol Bull 2007, 40:57-62.
13. Farooqi I.S. Monogenic human obesity. Front Horm Res 2008, 36:1-11.
14. Fernandez E., Carrizo E., Fernandez V., Connell L., Sandia I., Prieto D., et al. Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin. Schizophr Res 2010, 121:213-217.
15. Gauderman W.J., Morrison J.M. A computer program for power and sample size calculations for genetic-epidemiology studies http://hydra.usc.edu/gxe.
16. Gebhardt S., Theisen F.M., Haberhausen M., Heinzel-Gutenbrunner M., Wehmeier P.M., Krieg J.C., et al. Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study. J Clin Pharm Ther 2010, 35:207-211.
17. Gregoor J.G., van der Weide J., Mulder H., Cohen D., van Megen H.J., Egberts A.C., et al. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol 2009, 29:21-25.
18. Gregoor J.G., Mulder H., Cohen D., van Megen H.J., Egberts T.C., Heerdink E.R., et al. Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication. J Clin Psychopharmacol 2010, 30:702-705.
19. Gregoor J.G., van der Weide J., Loovers H.M., van Megen H.J., Egberts T.C., Heerdink E.R. Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication. Psychiatr Genet 2010, 20:311-316.
20. Gregoor J.G., van der Weide J., Loovers H.M., van Megen H.J., Egberts T.C., Heerdink E.R. Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics 2011, 12:919-923.
21. Hoffstedt J., Eriksson P., Mottagui-Tabar S., Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002, 34:355-359.
22. Kang S.G., Lee H.J., Park Y.M., Choi J.E., Han C., Kim Y.K., et al. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:160-163.
23. Kim S.F., Huang A.S., Snowman A.M., Teuscher C., Snyder S.H. From the cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci U S A 2007, 104:3456-3459.
24. Kuo P.H., Kao C.F., Chen P.Y., Chen C.H., Tsai Y.S., Lu M.L., et al. Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients. J Clin Psychopharmacol 2011, 31:705-711.
25. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444.
26. Lee A.K., Bishop J.R. Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications. Pharmacogenomics 2011, 12:999-1016.
27. Lett T.A., Wallace T.J., Chowdhury N.I., Tiwari A.K., Kennedy J.L., Muller D.J. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 2012, 17:242-266.
28. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007, 80:531-538.
29. Moons T., Claes S., Martens G.J., Peuskens J., Van Loo K.M., Van Schijndel J.E., et al. Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs. Schizophr Res 2011, 125:187-193.
30. Mou X.D., Zhang Z.J., Zhang X.R., Shi J.B., Sun J. -2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008, 33:316-320.
31. Muller D.J., Kennedy J.L. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics 2006, 7:863-887.
32. Muller D.J., De Luca V., Sicard T., King N., Hwang R., Volavka J., et al. Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. Eur Neuropsychopharmacol 2005, 15:525-531.
33. Muller D.J., Klempan T.A., De Luca V., Sicard T., Volavka J., Czobor P., et al. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett 2005, 379:81-89.
34. Opgen-Rhein C., Brandl E.J., Muller D.J., Neuhaus A.H., Tiwari A.K., Sander T., et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics 2010, 11:773-780.
35. Perez-Iglesias R., Mata I., Amado J.A., Berja A., Garcia-Unzueta M.T., Martinez Garcia O., et al. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment. J Clin Psychopharmacol 2010, 30:661-666.
36. Perkins D.O. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002, 63:1121-1128.
37. Reynolds G.P., Zhang Z.J., Zhang X.B. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 2002, 359:2086-2087.
38. Reynolds G.P., Templeman L.A., Zhang Z.J. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1021-1028.
39. Ruano G., Goethe J.W., Caley C., Woolley S., Holford T.R., Kocherla M., et al. Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients. Mol Psychiatry 2007, 12:474-482.
40. Ryu S.H.J., Jang W.S., Cho E.Y., Kim S.K., Lee D., Hong K.S. Association study of -2548A/G polymorphism of leptin gene with antipsychotics-induced weight gain. Korean J Psychopharmacol 2006, 17:423-428.
41. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
42. Sentissi O., Epelbaum J., Olie J.P., Poirier M.F. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull 2008, 34:1189-1199.
43. Sentissi O., Grouselle D., Viala A., Bourdel M.C., Olie J.P., Epelbaum J., et al. Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy. J Clin Psychopharmacol 2009, 29:304-306.
44. Srivastava V., Deshpande S.N., Nimgaonkar V.L., Lerer B., Thelma B. Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes. Pharmacogenomics 2008, 9:1055-1068.
45. Templeman L.A., Reynolds G.P., Arranz B., San L. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 2005, 15:195-200.
46. Theisen F.M., Gebhardt S., Haberhausen M., Heinzel-Gutenbrunner M., Wehmeier P.M., Krieg J.C., et al. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatr Genet 2005, 15:285-289.
47. Tiwari A.K., Rodgers J.B., Sicard M., Zai C.C., Likhodi O., Freeman N., et al. Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1484-1490.
48. Tiwari A.K., Zai C.C., Likhodi O., Lisker A., Singh D., Souza R.P., et al. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology 2010, 35:1315-1324.
49. Wang H.C., Yang Y.K., Chen P.S., Lee I.H., Yeh T.L., Lu R.B. Increased plasma leptin in antipsychotic-naive females with schizophrenia, but not in males. Neuropsychobiology 2007, 56:213-215.
50. Wehmeier P.M., Gebhardt S., Schmidtke J., Remschmidt H., Hebebrand J., Theisen F.M. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Psychiatry Res 2005, 133:273-276.
51. Weiden P.J., Mackell J.A., McDonnell D.D. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004, 66:51-57.
52. Wu R., Zhao J., Shao P., Ou J., Chang M. Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011, 36:720-723.
53. Yevtushenko O.O., Cooper S.J., O'Neill R., Doherty J.K., Woodside J.V., Reynolds G.P. Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Br J Psychiatry: J Ment Sci 2008, 192:424-428.
54. Zhang Z.J., Yao Z.J., Mou X.D., Chen J.F., Zhu R.X., Liu W., et al. Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain. Zhonghua Yi Xue Za Zhi 2003, 83:2119-2123.
55. Zhang X.Y., Tan Y.L., Zhou D.F., Haile C.N., Cao L.Y., Xu Q., et al. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J Clin Psychopharmacol 2007, 27:246-251.